XML 157 R3.htm IDEA: XBRL DOCUMENT v3.24.0.1
Consolidated Balance Sheets - USD ($)
$ in Thousands
Dec. 31, 2023
Dec. 31, 2022
Current assets:    
Cash and cash equivalents $ 126,590 $ 29,754
Marketable securities, current 127,091 246,399
Accounts receivable 11,799 1,473
Prepaid expenses and other current assets 5,709 9,931
Total current assets 271,189 287,557
Marketable securities, non-current 28,008 60,962
Property and equipment, net 7,132 7,400
Right-of-use asset 63,956 70,116
Restricted cash 3,443 3,279
Other assets 2,723 1,526
Total assets 376,451 430,840
Current liabilities:    
Accounts payable 1,446 1,172
Accrued expenses and other current liabilities 20,630 19,769
Deferred revenue, current 15,471 16,618
Operating lease liability, current 5,219 4,700
Long-term debt, net of debt discount—related party, current 0 2,287
Total current liabilities 42,766 44,546
Deferred revenue, net of current 21,814 16,895
Operating lease liability, net of current 65,757 70,970
Long-term debt, net of debt discount—related party, net of current 0 9,195
Total liabilities 130,337 141,606
Commitments and contingencies (See Note 6 and Note 9)
Stockholders’ equity:    
Preferred stock, par value of $0.0001 per share; 10,000,000 shares authorized, and no shares issued or outstanding as of December 31, 2023 and 2022, respectively 0 0
Common stock, par value of $0.0001 per share; 150,000,000 shares authorized, and 60,467,188 and 48,966,216 shares issued and outstanding as of December 31, 2023 and 2022, respectively 6 5
Additional paid-in capital 774,618 689,256
Accumulated other comprehensive loss (127) (4,137)
Accumulated deficit (528,383) (395,890)
Total stockholders’ equity 246,114 289,234
Total liabilities and stockholders’ equity $ 376,451 $ 430,840